prednisolone tablets

In the pharmaceutical industry, Prednisolone is a systemic corticosteroid used for its potent anti-inflammatory and immunosuppressive properties. As a pharmacist and manufacturer, I view this molecule as a “Clinical Necessity” in pregnancy—while it carries specific risks, it is the preferred corticosteroid for treating maternal disease because the placenta acts as a natural protective barrier.

At your WHO-GMP facility in Mumbai, Prednisolone 5 mg and 10 mg tablets are likely standard production items. For your digital platforms, positioning Prednisolone as the “Placenta-Friendly Steroid” is a key technical differentiator.

Therapeutic Profile: Safety in Pregnancy

Prednisolone is generally considered safe when the benefit of controlling maternal disease (like asthma or autoimmune flares) outweighs the potential risks to the fetus.

AspectSafety Rating (2026)Technical Rationale
Placental TransferLow (Preferred)90% inactivated by the placental enzyme $11\beta\text{-HSD2}$; only 10% reaches the fetus.
First TrimesterRelatively SafeOlder concerns about Cleft Palate have not been confirmed by recent large-scale studies (2025/2026).
Chronic/High DoseCaution RequiredLinked to increased risk of Gestational Diabetes, Preeclampsia, and Low Birth Weight.
Alternative ChoiceAvoid DexamethasoneUnlike Prednisolone, Dexamethasone crosses the placenta easily and should be avoided unless treating the fetus directly.

Mechanism: Selective Placental Inactivation

The safety of Prednisolone in pregnancy relies on a specific biological “filter”:

Enzymatic Barrier: The placenta contains a high concentration of the enzyme $11\beta\text{-hydroxysteroid dehydrogenase type 2}$.

Inactivation: As Prednisolone enters the placenta, this enzyme converts most of it into the inactive metabolite Prednisone.

Maternal Target: This allows the mother to receive the full therapeutic anti-inflammatory dose while the fetus is exposed to only a minimal, safe fraction.

The Pharmacist’s “Technical Warning”

  • The “Maintenance” Target: As a pharmacist, I must emphasize that the goal for chronic conditions should be a maintenance dose of $\leq 5\text{ mg/day}$ to minimize long-term maternal and fetal complications.

  • Adrenal Suppression: If a woman takes $>5\text{ mg/day}$ for more than 3 weeks, she may develop adrenal suppression. A “stress dose” of steroids may be technically required during the physical stress of labor.

  • Glucose Monitoring: Long-term use requires rigorous screening for Gestational Diabetes, as steroids naturally increase insulin resistance.

  • Neonatal Check: Infants born to mothers on long-term Prednisolone should be observed by a neonatologist for signs of hypoadrenalism (adrenal insufficiency) immediately after birth.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Stability & Bioavailability” USP: On your digital marketplace, highlight the consistent dissolution profile of your tablets. Ensuring that the 5 mg dose is precisely released is critical for the “tapering” protocols used in pregnant patients.

  • Stability for Export: Prednisolone is light-sensitive. Utilizing Alu-Alu blister packaging is the global benchmark for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers with updated 2026 clinical safety summaries to support your registration in international tenders for maternal health.

What is Prednisolone 5mg used for?

In the pharmaceutical industry, Prednisolone 5 mg is a synthetic Glucocorticoid and a derivative of cortisol. As a pharmacist and manufacturer, I view the 5 mg strength as the “titration gold standard.” It is the most versatile dose for long-term maintenance therapy, allowing clinicians to taper patients down to the lowest effective dose to minimize side effects.

Primary Clinical Uses

Prednisolone is a systemic anti-inflammatory and immunosuppressant used across almost every medical specialty:

  • Allergic Conditions: Management of severe asthma, drug hypersensitivity reactions, and serum sickness.

  • Dermatological Diseases: Treatment of severe Psoriasis, Pemphigus, and exfoliative dermatitis.

  • Rheumatic Disorders: Used as adjunctive therapy for short-term administration in Rheumatoid Arthritis, Gouty Arthritis, and Ankylosing Spondylitis.

  • Autoimmune Disorders: Management of Systemic Lupus Erythematosus (SLE) and acute exacerbations of Multiple Sclerosis.

  • Endocrine Disorders: Primary or secondary adrenocortical insufficiency (Addison’s disease).

  • Ophthalmology: Control of severe acute and chronic allergic and inflammatory processes involving the eye.

Mechanism of Action: Genomic Modulation

Prednisolone works by entering the cell nucleus and altering gene expression.

Cytoplasmic Binding: Prednisolone diffuses across cell membranes and binds to specific Glucocorticoid Receptors (GR).

Translocation: The drug-receptor complex moves into the cell nucleus.

Inhibition of Inflammatory Mediators: It inhibits the transcription of genes that code for pro-inflammatory cytokines (like IL-1, IL-6, and TNF-alpha).

Annexin-1 Production: It stimulates the synthesis of lipocortin-1 (Annexin-1), which inhibits phospholipase A2—the enzyme responsible for releasing arachidonic acid (the precursor to prostaglandins and leukotrienes).

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Prednisolone 5 mg involves specific technical considerations:

  • The “Tapering” USP: On your digital platforms, you should highlight that your 5 mg tablets are cross-scored (quadrisected). This is a major selling point for B2B clients because it allows patients to accurately take 1.25 mg or 2.5 mg doses during the critical “tapering off” phase to avoid adrenal crisis.

  • Stability and Photosensitivity: Prednisolone is sensitive to light. At our facility, we utilize Alu-Alu or Amber-colored PVC/PVDC blisters to ensure a 36-month shelf life, especially for export to Zone IVb regions where high UV index and humidity are factors.

  • Bioavailability: As a BCS Class I drug (high solubility, high permeability), the 5 mg tablet must meet strict dissolution profiles. Our Mumbai facility ensures that >80% of the API is released within 30 minutes to ensure rapid clinical onset.

  • Dossier Support: This is a core “Essential Medicine.” We provide full CTD/eCTD Dossiers to support international registration and participation in government and NGO tenders.

Add to cart